Back to Results
First PageMeta Content
Medicine / Isoxazoles / Analgesics / Valdecoxib / Pfizer / Stevens–Johnson syndrome / Toxic epidermal necrolysis / Postmarketing surveillance / Erythroderma / Sulfonamides / Drug eruptions / Health


Microsoft Word - LETTER W/ LOGO
Add to Reading List

Open Document

File Size: 466,67 KB

Share Result on Facebook

City

New York / North Peapack / /

Company

Pfizer / Pain Global Medical Affairs Pharmacia Corporation / Pharmacia Corporation / Worldwide Team Pfizer Inc / /

Event

FDA Phase / /

/

IndustryTerm

healthcare professionals / /

MedicalCondition

Stevens-Johnson syndrome / adult rheumatoid arthritis / osteoarthritis / Medical Director Arthritis / angioedema / erythema multiforme / anaphylactic reactions / hypersensitivity / skin rash / toxic epidermal necrolysis / exfoliative dermatitis / /

Organization

FDA / /

Person

Mona M. Wahba / James B. Jones / /

/

Position

Director Arthritis / Medical Director / /

Product

BEXTRA / BEXTRA® (valdecoxib tablets) / /

ProvinceOrState

New Jersey / New York / /

URL

www.accessdata.fda.gov/scripts/medwatch / /

SocialTag